ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Inhixa 4000 IE (40 mg), Injektionslösung - 50
67454006 Viatris Pharma GmbH
Inhixa 4000 IE (40 mg), Injektionslösung10.06.2020
  10.06.2020
Enoxaparin (B01AB05) 
WHO-DDD09.06.2025
06.03.30.50
06.03.30. 
B  
Yes 
IP 
140.69Yes
    
10 %169.40
7680674540069Biotechnologika
7769359 
Composition
enoxaparinum natricum 40 mg corresp. 4000 U.I. anti-Xa, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.23 mmol.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Enoxaparin Sodium40 mg
BAG: Active AgentDose
Enoxaparin Sodium40 mg
 
Inactive agents
Anti-Xa
 
Source
Data was imported : 07.10.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home